Enact Holdings, Inc.
Enact Holdings, Inc. (ACT) Financial Performance & Income Statement Overview
Analyze Enact Holdings, Inc. (ACT) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Enact Holdings, Inc. (ACT) Income Statement & Financial Overview
Review Enact Holdings, Inc. ACT income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $306.78M | $304.69M | $309.59M | $298.83M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $2.21M |
| Gross Profit | $306.78M | $304.69M | $309.59M | $296.63M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.99 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $112.50M |
| Operating Expenses | $50.09M | $96.84M | $53.09M | $56.25M |
| Total Costs & Expenses | $50.09M | $114.71M | $53.09M | -$39.43M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $12.29M | $12.26M | $12.29M | $13.64M |
| Depreciation & Amortization | $0.00 | $199.85M | $0.00 | $19.03M |
| EBITDA | $0.00 | $419.97M | $0.00 | $0.00 |
| EBITDA Ratio | $0.00 | $1.38 | $0.00 | $0.00 |
| Operating Income | $256.68M | $207.85M | $256.50M | $229.44M |
| Operating Income Ratio | $0.84 | $0.68 | $0.83 | $0.77 |
| Other Income/Expenses (Net) | -$45.26M | $0.00 | -$27.04M | -$64.005M |
| Income Before Tax | $211.42M | $207.85M | $229.46M | $234.83M |
| Income Before Tax Ratio | $0.69 | $0.68 | $0.74 | $0.79 |
| Income Tax Expense | $45.64M | $45.12M | $48.79M | $51.16M |
| Net Income | $165.78M | $162.74M | $180.67M | $183.67M |
| Net Income Ratio | $0.54 | $0.53 | $0.58 | $0.61 |
| EPS | $1.09 | $1.06 | $1.16 | $1.17 |
| Diluted EPS | $1.08 | $1.05 | $1.15 | $1.16 |
| Weighted Avg Shares Outstanding | $151.83M | $153.54M | $155.56M | $157.19M |
| Weighted Avg Shares Outstanding (Diluted) | $152.91M | $154.54M | $157.02M | $158.57M |
Over the past four quarters, Enact Holdings, Inc. demonstrated steady revenue growth, increasing from $298.83M in Q2 2024 to $306.78M in Q1 2025. Operating income reached $256.68M in Q1 2025, maintaining a consistent 84% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $165.78M, with EPS at $1.09. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan